Evidence map›Paper›PMID 35848891›Full record

ArticleCancer science2022

Tumor microenvironmental 15-PGDH depletion promotes fibrotic tumor formation and angiogenesis in pancreatic cancer.

Luke Bu, Atsuko Yonemura, Noriko Yasuda-Yoshihara, Tomoyuki Uchihara, Galym Ismagulov, Sanae Takasugi, Tadahito Yasuda, Yuya Okamoto, Fumimasa Kitamura, Takahiko Akiyama and 14 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 2 countries.

Luke BuDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Atsuko YonemuraDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Noriko Yasuda-YoshiharaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tomoyuki UchiharaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Galym IsmagulovDevelopmental Morphogenesis, IRCMS, Kumamoto University, Kumamoto, Japan.
Sanae TakasugiApplication Department, X-ray Division, Bruker Japan K.K., Kanagawa, Japan.
Tadahito YasudaGastrointestinal Cancer Biology, International Research Center of Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
Yuya OkamotoDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Fumimasa KitamuraDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Takahiko AkiyamaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kota ArimaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Rumi ItoyamaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Jun ZhangDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Lingfeng FuDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Xichen HuDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Feng WeiDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yuichiro ArimaDevelopmental Cardiology, IRCMS, Kumamoto University, Kumamoto, Japan.
Toshiro MoroishiDepartment of Cell Signaling and Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0001-6419-3882
Koichi NishiyamaLaboratory of Vascular and Cellular Dynamics, Department of Medical Sciences, University of Miyazaki, Miyazaki City, Japan.
Guojun ShengDevelopmental Morphogenesis, IRCMS, Kumamoto University, Kumamoto, Japan.
Toshifumi MukunokiX-Earth Center, Faculty of Advanced Science and Technology Kumamoto University, Kumamoto, Japan.
Jun OtaniX-Earth Center, Faculty of Advanced Science and Technology Kumamoto University, Kumamoto, Japan.
Hideo BabaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-3474-2550
Takatsugu IshimotoDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0003-1852-1835
Kumamoto University · JPKumamoto University Hospital · JPKumamoto Health Science University · JPBruker (United States) · USUniversity of Miyazaki · JP

Funding

Japan Science and Technology Agency JPMJFR200HJapan Society for the Promotion of Science 20H03531Japan Society for the Promotion of Science 20K08985Japan Society for the Promotion of Science 20K09038Japan Society for the Promotion of Science 21K19535Naito FoundationThe Shinnihon Foundation of Advanced Medical Treatment Research
6 · The paper itself

Abstract

The arachidonic acid cascade is a major inflammatory pathway that produces prostaglandin E

Indexed as

Pancreatic NeoplasmsVascular Endothelial Growth Factor AAnimalsArachidonic AcidCell Line, TumorDinoprostoneFibroblast Growth Factor 1FibrosisHydroxyprostaglandin DehydrogenasesMiceTumor Microenvironment15-hydroxyprostaglandin dehydrogenaseArachidonic AcidDinoprostoneFibroblast Growth Factor 1Hydroxyprostaglandin DehydrogenasesVascular Endothelial Growth Factor Acancer-associated fibroblastsprostaglandin E2tumor microenvironment

Identifiers

PMID35848891
PMCPMC9530869
OpenAlexW4285728278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.